Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NR2F6 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZFYVE1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | SPTB | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
mRNA | LCMT1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
mRNA | MNDA | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
mRNA | GRAP | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | NUDT19 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
mRNA | VN1R4 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
mRNA | STAB2 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
mRNA | ITGA2B | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |